Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-07-000400
Filing Date
2007-12-14
Accepted
2007-12-14 08:49:23
Documents
1
Period of Report
2007-12-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8885
  Complete submission text file 0000908662-07-000400.txt   10948
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5083705261
COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 071305984
SIC: 2836 Biological Products, (No Diagnostic Substances)